Cambridge Centre for Lung Infection, Papworth Hospital NHS Foundation Trust, Cambridge, UK.
Eur J Immunol. 2013 Feb;43(2):323-6. doi: 10.1002/eji.201243263.
Prior murine studies have demonstrated the pivotal role that Blimp-1 has in the exhausted phenotype of T lymphocytes in chronic viral infection. In this issue of the European Journal of Immunology, Seddiki et al. [Eur. J. Immunol. 2013. 43: 510-520] demonstrate the applicability of this research to HIV infection. The authors do so by demonstrating differences in Blimp-1 expression between T lymphocytes isolated from patients with chronic active HIV versus those from long-term nonprogressors and showing that this is matched by differences in the cells' capacity to produce IL-2 and the level of expression of the inhibitory receptor PD-1. The data presented here suggest that this may relate to differential regulation of Blimp-1 by the micro RNA, mIR-9. These findings complement current murine work and fit squarely within the research priorities, as outlined by the International AIDS Society, for determining a cure for AIDS.
先前的鼠类研究表明,Blimp-1 在慢性病毒感染中 T 淋巴细胞耗竭表型中具有关键作用。在本期的《欧洲免疫学杂志》中,Seddiki 等人[Eur. J. Immunol. 2013. 43: 510-520]证明了这一研究在 HIV 感染中的适用性。作者通过证明从慢性活动性 HIV 患者中分离的 T 淋巴细胞与从长期非进展者中分离的 T 淋巴细胞之间 Blimp-1 表达的差异,并表明这与细胞产生 IL-2 的能力和抑制性受体 PD-1 的表达水平的差异相匹配,证明了这一点。这里提出的数据表明,这可能与 microRNA mIR-9 对 Blimp-1 的差异调节有关。这些发现补充了当前的鼠类研究工作,并完全符合国际艾滋病协会确定艾滋病治愈方法的研究重点。